NCT05710159View on ClinicalTrials.gov

The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

December 30, 2024

Conditions
Bladder Cancer
Interventions
DEVICE

iBLAD Application to monitor symptoms and quality of life by the use of pateint-reported outcomes

Development and implementation of a national multimodality application for patients with bladder cancer that builds upon knowledge from the iBLAD study.

Trial Locations (2)

2100

NOT_YET_RECRUITING

Rigshospitalet, Copenhagen

5000

RECRUITING

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Danish Cancer Society

OTHER

lead

Odense University Hospital

OTHER